ACADIA Pharmaceuticals
ACAD
#3690
Rank
NZ$4.75 B
Marketcap
$28.58
Share price
-1.47%
Change (1 day)
-23.65%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) Fails to deliver data

Key failure to deliver metrics for ACADIA Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for ACADIA Pharmaceuticals (ACAD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for ACADIA Pharmaceuticals (ACAD) - since 2013

Volume in USD (price x number of shares), data since 2013

ACADIA Pharmaceuticals (ACAD) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$3.1 M-62.27%
2023NZ$8.22 M-40.53%
2022NZ$13.82 M-74.37%
2021NZ$53.95 M331.32%
2020NZ$12.5 M-67.15%
2019NZ$38.08 M-55.46%
2018NZ$85.49 M16.96%
2017NZ$73.09 M-16.52%
2016NZ$87.57 M150.41%
2015NZ$34.97 M-4.6%
2014NZ$36.65 M225.43%
2013NZ$11.26 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$0.03 MNZ$1.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.21 MNZ$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$41.73 MNZ$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$70.18 MNZ$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.95 MNZ$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA